List prices for brand-name drugs have risen steeply, often despite the introduction of competition from other brand-name drugs in the same therapeutic class. List prices, however, do not reflect any ...

While prescription medication prices are no longer the fastest-growing commodity or service, prescription drug costs have still increased 2.5% since the beginning of the COVID-19 pandemic, according ...

The US Food and Drug Administration kept up a blistering pace of new drug approvals last year, all while navigating the urgent evaluation of tests, drugs, and vaccines in development for COVID-19. The ...

Aayan N. Patel is a researcher in the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ...